Do gene polymorphism in IL-1β, TNF-α and IL-6 influence therapeutic response in patients with drug refractory epilepsy?

Epilepsy Research

Volumn 101, Issue 3, 2012, Pages 261-267

  Tiwari, Prabhakar ^a   Dwivedi, Rekha ^b   Mansoori, Nasim ^b   Alam, Rizwan ^b   Chauhan, Ugam Kumari ^a   Tripathi, Manjari ^b   Mukhopadhyay, Asok Kumar ^b  

^a Awahdesh Pratap Singh University   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Drug Refractory Epilepsy; Polymorphism; Seizures; SNPs; Therapeutic response

Indexed keywords

ADENINE; CYTOSINE; GUANINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; THYMINE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGE; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CHILD; CONTROLLED STUDY; DRUG RESPONSE; EPILEPSY; FEMALE; GENE; GENE FREQUENCY; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IL1BETA GENE; IL6 GENE; INDIAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SCHOOL CHILD; SEIZURE SUSCEPTIBILITY; SEX RATIO; TNF ALPHA GENE;

ADOLESCENT; ADULT; AGED; ALLELES; CHILD; EPILEPSY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INDIA; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; PHARMACOGENETICS; POLYMORPHISM, GENETIC; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866165845     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2012.04.013     Document Type: Article

References (29)

1. Bagli M., Papassotiropoulos A., Knapp M., et al. Association between an interleukin-6 promoter and 3 flanking region haplotype and reduced Alzheimer's disease risk in a German population. Neurosci. Lett. 2000, 283:109-112.
2. Buono R.J., Ferraro T.N., O'Connor M.J., et al. Lack of association between an interleukin 1 beta (IL-1b) gene variation and refractory temporal lobe epilepsy. Epilepsia 2001, 42:782-784.
3. Capurso C., Solfrizzi V., Colacicco A.M., et al. Interleukin-6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:177-182.
4. Chou I.C., Lin W.D., Wang C.H., et al. Interleukin (IL)-1β, IL-1 receptor antagonist, IL-6, IL-8, IL-10, and tumor necrosis factor-α gene polymorphism in patients with febrile seizures. J. Clin. Lab. Anal. 2010, 24:154-159.
5. Chou I.C., Tsai C.H., Hsieh Y.Y., Peng C.T., Tsai F.J. Association between polymorphism of interleukin -1 beta-511 promoter and susceptibility to febrile convulsions in Taiwanese children. Acta Paediatr. 2003, 92:1356.
6. Duan S., Xu Y., Chen W. No association between the promoter variants of tumor necrosis factor alpha (TNF-alpha) and schizophrenia in Chinese Han population. Neurosci. Lett. 2004, 366:139-143.
7. Fishman D., Faulds G., Jeffery R., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 1998, 102(7):1369-1376.
8. Hashimoto R., Yoshida M., Ozaki N. Association analysis of the -308GA promoter polymorphism of the tumor necrosis factor alpha (TNF-alpha) gene in Japanese patients with schizophrenia. J. Neural. Transm. 2004, 111:217-221.
9. Haspolat S., Baysal Y., Duman O., Coskun M., Tosun O., Yegin O. Interleukin-1alpha, interleukin-1beta, and interleukin-1Ra polymorphisms in febrile seizures. J. Child Neurol. 2005, 20:565-568.
10. Heils A., Haug K., Kunz W.S., et al. Interleukin-1-beta polymorphism and susceptibility to temporal lobe epilepsy with hippocampal sclerosis. Ann. Neurol. 2000, 48:948-950.
11. Kanemoto K., Kawasaki J., Miyamoto T., Obayashi H., Nishimura M. Interleukin (IL) 1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann. Neurol. 2000, 47:571-574.
12. Kanemoto K., Kawasaki J., Yuasa S., et al. Increased frequency of interleukin-1β-511 T allele in patients with temporal lobe epilepsy, hippocampal sclerosis, and prolonged febrile convulsion. Epilepsia 2003, 44:796-799.
13. Kira R., Ishizaki Y., Torisu H., et al. Genetic susceptibility to febrile seizures: case-control association studies. Brain Dev. 2010, 32:57-63.
14. Kira R., Torisu H., Takemoto M., et al. Genetic susceptibility to simple febrile seizures: interleukin-1beta promoter polymorphisms are associated with sporadic cases. Neurosci. Lett. 2005, 384:239-244.
15. Lehtimaki K.A., Keränen T., Palmio J., Mäkinen R., Hurme M., Honkaniemi J., et al. Increased plasma levels of cytokines after seizures in localization-related epilepsy. Acta Neurol. Scand. 2007, 116:226-230.
16. Lehtimäki K.A., Liimatainen S., Peltola J., et al. The serum level of interleukin-6 in patients with intellectual disability and refractory epilepsy. Epilepsy Res. 2011, 95:184-187.
17. Li G., Bauer S., Nowak M., et al. Cytokines and epilepsy. Seizure 2011, 20:249-256.
18. Mansoori N., Tripathi M., Alam R., et al. IL-6-174 G/C and ApoE gene polymorphism in Alzhemer's and vascular dermentia patients attending the cognitive disorder clinic of the All India Institute of Medical Sciences, New Delhi. Dement. Geriatr. Cogn. Disord. 2010, 30:461-468.
19. Mateo I., Infante J., Rodríguez E., et al. Interaction between dopamine beta-hydroxylase and interleukin genes increases Alzheimer's disease risk. J. Neurol. Neurosurg. Psychiatry 2006, 77:278-279.
20. Matsuo M., Sasaki K., Ichimaru T., Nakazato S., Hamasaki Y. Increased IL1beta production from dsRNA-stimulated leukocytes in febrile seizures. Pediatr. Neurol. 2006, 35:102-106.
21. Nur B.G., Kahramaner Z., Duman O., et al. Inrerleukin-6 gene polymorphism in febrile seizures. Pediatr. Neurol. 2012, 46(January (1)):36-38.
22. Ozkara C., Uzan M., Tanriverdi T., et al. Lack of association between IL-1beta/alpha gene polymorphisms and temporal lobe epilepsy with hippocampal sclerosis. Seizure 2006, 15:288-291.
23. Pae C.U., Chae J.H., Bahk W.M. Tumor necrosis factor-alpha gene polymorphism at position 308 and schizophrenia in the Korean population. Psychiatry Clin. Neurosci. 2003, 57:399-403.
24. Pola, R., Flex, A., Gaetani, E., 2002. The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population.
25. Shibata N., Ohnuma T., Takahashi T., et al. Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases. Am. J. Med. Genet. 2002, 114:436-439.
26. Sinha S., Patil S.A., Jayalekshmy V., Satishchandra P. Do cytokines have any role in epilepsy?. Epilepsy Res. 2008, 82:171-176.
27. Tilgen N., Pfeiffer H., Cobilanschi J., et al. Association analysis between the human interleukin-1beta (-511) gene polymorphism and susceptibility to febrile convulsions. Neurosci. Lett. 2002, 334:68-70.
28. Virta M., Hurme M., Helminen M. Increased plasma levels of pro- and anti-inflammatory cytokines in patients with febrile seizures. Epilepsia 2002, 43:920-923.
29. Wieser F., Fabjani G., Tempfer C., et al. Tumor necrosis factor-alpha promoter polymorphisms and endometriosis. J. Soc. Gynecol. Investig. 2002, 9:313-318.